Evidence map›Paper›PMID 29868350›Full record

ArticleNanotheranostics2018

Clinically-Applicable Perfluorocarbon-Loaded Nanoparticles For

Edyta Swider, Khalid Daoudi, Alexander H J Staal, Olga Koshkina, N Koen van Riessen, Eric van Dinther, I Jolanda M de Vries, Chris L de Korte, Mangala Srinivas

Open access · goldAbstract read
In one paragraph

Article in Nanotheranostics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Perfluorocarbon-Loaded Poly(lactide-ACS applied polymer materials · 2025
    Article
  3. Polymeric (Poly(lactic-ACS omega · 2025
    Article
  4. Article
  5. Article
  6. Perfluorocarbons: A perspective of theranostic applications and challenges.Frontiers in bioengineering and biotechnology · 2023
    Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. DNA Nanostructures and DNA-Functionalized Nanoparticles for Cancer Theranostics.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2020
    Review
  17. Article
  18. Review
  19. Perfluorocarbons-BasedInternational journal of nanomedicine · 2020
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Edyta SwiderDepartment of Tumor Immunology, Radboud University Medical Center, Nijmegen, The Netherlands.
Khalid DaoudiMedical UltraSound Imaging Center (MUSIC), Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
Alexander H J StaalDepartment of Tumor Immunology, Radboud University Medical Center, Nijmegen, The Netherlands.
Olga KoshkinaDepartment of Tumor Immunology, Radboud University Medical Center, Nijmegen, The Netherlands.
N Koen van RiessenDepartment of Tumor Immunology, Radboud University Medical Center, Nijmegen, The Netherlands.
Eric van DintherDepartment of Tumor Immunology, Radboud University Medical Center, Nijmegen, The Netherlands.
I Jolanda M de VriesDepartment of Tumor Immunology, Radboud University Medical Center, Nijmegen, The Netherlands.
Chris L de KorteMedical UltraSound Imaging Center (MUSIC), Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
Mangala SrinivasDepartment of Tumor Immunology, Radboud University Medical Center, Nijmegen, The Netherlands.
Radboud University Medical Center · NLRadboud University Nijmegen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Photoacoustic imaging (PAI) is an emerging biomedical imaging technique that is now coming to the clinic. It has a penetration depth of a few centimeters and generates useful endogenous contrast, particularly from melanin and oxy-/deoxyhemoglobin. Indocyanine green (ICG) is a Food and Drug Administration-approved contrast agents for human applications, which can be also used in PAI. It is a small molecule dye with limited applications due to its fast clearance, rapid protein binding, and bleaching effect.

Indexed as

19F MRIindocyanine greenmultimodal imagingnanoparticlesperfluoro-15-crown-5-ether

Identifiers

PMID29868350
PMCPMC5984288
OpenAlexW2806441219

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.